Our Team
Raju Prasad
BOARD MEMBER
Dr Raju Prasad is a board member at Averna Therapeutics and has served as Chief Financial Officer of CRISPR Therapeutics since March 2023. Prior to joining CRISPR, he was a partner and senior biotechnology analyst at William Blair & Company, where he led the firm’s initiatives in cell, gene, and gene-editing therapies—covering small- to large-cap companies. Earlier in his career, he worked as a research associate at UNC Chapel Hill’s Gillings School of Global Public Health and as an independent consultant with the US Environmental Protection Agency.
He holds a BA from Rutgers, an MS from the University of Delaware, and a PhD from UNC Chapel Hill. He is also the author of Building Breakthroughs: On the Frontier of Medical Innovation.